3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
16
Oropharyngeal Neoplasms
10
Nasopharyngeal Carcinoma
10
Prostatic Neoplasms
7
Laryngeal Neoplasms
6
Rectal Neoplasms
5
Mouth Neoplasms
5
Hypopharyngeal Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Epstein-Barr Virus Infections
2
Carcinoma, Intraductal, Noninfiltrating
2
Astrocytoma
2
Anus Neoplasms
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomatitis
1
Stomach Neoplasms
1
Interventions
pembrolizumab
38
Bevacizumab
23
Cyclophosphamide
22
Standard of Care
18
Blood Specimen Collection
17
Carboplatin
16
Paclitaxel
15
Nivolumab
14
Gemcitabine
14
Pemetrexed
13
Exercise
13
Cisplatin
12
atezolizumab
11
Radiotherapy
11
Fluorouracil
11
Doxorubicin
11
Surveys and Questionnaires
9
Rituximab
9
Oxaliplatin
9
Magnetic Resonance Spectroscopy
9
Leucovorin
9
Cetuximab
9
Biopsy
9
130-nm albumin-bound paclitaxel
9
durvalumab
8
abemaciclib
8
Docetaxel
8
olaparib
7
Temozolomide
7
Prednisone
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Radiotherapy, Intensity-Modulated
×
90 days
×
Clear all
No trials found.